SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FUST (Fusion token) is the companion token of FUSD - with tokenomics which mirror those of a typical cryptocurrency. FUST can be placed in the FUST Fusion Miner and used to mine free FUSD. FUST has tokenomics which mirror those of a typical cryptocurrency, and allows those Degens who buy into the FUSD philosophy - but who also enjoy the thrill of chasing fast green candles - to make their play within the structure of the FUSD ecosystem and benefit from the best of both worlds; the possibility of a fast ride upwards whilst earning a passive income paid in our appreciating stable token courtesy of their FUST bag.

FUST Token

The FUST community is rallying around the token's unique ecosystem, which focuses on generating passive income through its appreciating stablecoin, FUSD. Investors are highlighting this yield-focused model as a sustainable alternative to traditional stablecoins, fueling anticipation for future growth and platform developments.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The semiconductor sector is currently experiencing heightened volatility and intense debate as traders weigh the risks of an 'AI bubble' against strong demand fundamentals. Market sentiment remains divided, with the community actively debating whether recent pullbacks represent healthy consolidation or a structural exhaustion of the long-term trend.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing investor attention through a combination of technical strength, whale accumulation, and anticipation of upcoming network upgrades that promise increased programmability. The community is actively debating its potential to decouple from Bitcoin and reclaim its historical role as a peer-to-peer electronic cash system, with many investors maintaining a bullish long-term outlook.

WorldFinancial

World Liberty Financial ($WLFI) is facing intense scrutiny and volatility following reports of a congressional investigation into its foreign capital dealings and a high-value stake acquisition by UAE-linked investors. The community remains sharply divided, with supporters viewing recent price dips as a strategic buying opportunity tied to potential institutional adoption, while critics continue to label the project as a high-risk venture and a vehicle for self-enrichment.

VanEck ETF Trust - VanEck Agribusiness ETF

VanEck Agribusiness ETF

Investors are increasingly rotating into the agribusiness sector, driving fresh inflows into $MOO as the community anticipates potential food supply constraints and favorable shifts in global agricultural demand. Market participants are actively comparing the VanEck Agribusiness ETF to direct commodity futures, highlighting its appeal as an equity-based defensive play for those seeking structural growth outside of the tech sector.

RAWW MILK COIN

Investors are rallying behind RAWW, a memecoin that has sustained its community for over a year by building an ecosystem of webtoons, games, and music rather than relying on short-term hype. The project is trending as supporters contrast its consistent, unconventional content with traditional market volatility, framing their commitment to the token as a lifestyle-driven "milk-pilled" movement.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is trending as investors debate the impact of the Digital Asset Market Clarity Act, which could permanently codify the token as a digital commodity and potentially unlock long-term institutional interest. While the community remains divided between speculative hopes of burning supply to reach higher price levels and frustration over extended periods of consolidation, many long-term holders continue to view current price action as a strategic accumulation zone.

Banco de Chile SA engages in the provision of banking services. It operates through the following segments: Retail Banking, Wholesale Banking, Treasury, and Money Markets, and Subsidiaries. The Retail Banking segment consists of consumer loans, commercial loans, checking accounts, credit cards, credit lines, and mortgage loans. The Wholesale Banking segment includes corporate clients and large companies where the product offering focuses on commercial loans, checking accounts and liquidity management services, debt instruments, foreign trade, derivative contracts, and leases. The Treasury and Money Markets segment comprises securities portfolio, derivatives positions, and currency trading. The Subsidiaries segment corresponds to companies and corporations controlled by the bank. The company was founded on October 28, 1893 and is headquartered in Santiago, Chile.

Banco de Chile - ADR

Banco de Chile

Banco de Chile is currently experiencing heightened investor attention, with the community actively discussing whale accumulation patterns and the bank's role as a defensive, income-generating asset. Traders are closely monitoring key chart levels and technical indicators as the stock maintains strong support despite broader market volatility.

What is Tron? Tron's mission is to build a truly decentralized internet and aims to be the largest blockchain-based operating system in the world, known as the TRON protocol. The TRON protocol will offer high scalability, high availability, and high throughput computing to serve decentralized applications via smart contracts. Ethereum EVM-based smart contracts will be compatible and deployable on the TRON network as such Solidity developers do not have to rewrite their applications.  Why Tron? Since TRON protocol does not rely on proof of work or mining, instead governed by nodes located around the world, it is decentralized while providing high throughput for transactions on the blockchain. This is suitable for dapps that require high speed transactions especially games. There are a number of tokens already issued on the TRON network and the decentralized exchanges TRX.market has launched.  On July 24th 2018, TRON acquired BitTorrent, one of the largest P2P file sharing protocol. As a result of the acquisition, BitTorrent Token (BTT) was launched as the cryptocurrency to power the economics on the BitTorrent network. The Token will be used to inceltivize file sharing and storage within the network.

Tron

Tron is generating significant community interest, driven by its expanding role in stablecoin settlements and partnerships with major platforms like Rumble. Investors are actively discussing the asset's resilience during market corrections and are optimistic about its long-term growth potential within the broader digital finance ecosystem.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending as investors weigh strong commercial product performance, including the recent FDA approval for EMPAVELI in rare kidney diseases, against ongoing frustration with management's transparency and inconsistent stock price recovery. The community remains focused on potential M&A scenarios and the company's ability to maintain growth in its core geographic atrophy portfolio amidst high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mak Capital One LLC Buys 9,062,518 Shares of Autolus Therapeutics PLC Sponsored ADR $AUTL

Mak Capital One LLC lifted its stake in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) by 53.5% in the third quarter, according to the company in its most recent disclosure with...

Autolus Therapeutics (AUTL) Projected to Post Earnings on Thursday

Autolus Therapeutics (NASDAQ:AUTL) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...

Autolus Therapeutics Touts $75M Year-1 Obe-cel Launch, Sees $120M-$135M Revenue in 2026

Autolus Therapeutics (NASDAQ:AUTL) Chief Executive Officer Christian Itin told conference attendees the company is entering its second year as a commercial-stage business following the launch of its...

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of "Hold" by Brokerages

Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) have received a consensus recommendation of "Hold" from the seven brokerages that are presently covering the stock...

Traders Buy Large Volume of Autolus Therapeutics Call Options (NASDAQ:AUTL)

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) was the target of unusually large options trading activity on Monday. Traders purchased 2,496 call options on the stock. This...

Q1 Earnings Forecast for AUTL Issued By HC Wainwright

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Autolus Therapeutics in a research report issued...

What is HC Wainwright's Estimate for AUTL FY2025 Earnings?

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) - Investment analysts at HC Wainwright issued their FY2025 earnings per share (EPS) estimates for shares of Autolus Therapeutics in...

Autolus Therapeutics (NASDAQ:AUTL) Rating Increased to Strong-Buy at HC Wainwright

HC Wainwright raised shares of Autolus Therapeutics to a "strong-buy" rating in a report on Tuesday...

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Hold" by Brokerages

Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) has been given an average recommendation of "Hold" by the six brokerages that are presently covering the stock, Marketbeat...

New Strong Sell Stocks for January 30th

TSE, PAC and AUTL have been added to the Zacks Rank #5 (Strong Sell) List on January 30th, 2026.

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.

Current Price	$1.37
Prev Close	$1.43
Open	$1.43
Dividend Yield	0.00%
50-Day Moving Average	$1.52
Beta	1.36
Avg. Volume	1.57M
PE Ratio	-1.62

52-Week High	$2.70
52-Week Low	$1.11
Market Capitalization	$364.62M
EPS (Annual)	-$0.8652
Price to Book	1.83
Revenue Per Employee	$15,648.00

AUTL
Autolus Therapeutics Ltd - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AUTL News

AUTLAutolus Therapeutics Ltd - ADR